British American Tobacco PLC Block listing Interim Review

RNS Number : 9649R

British American Tobacco PLC

02 January 2025

 

SCHEDULE 5

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of company

BRITISH AMERICAN TOBACCO P.L.C.

2. Name of scheme

A)           BRITISH AMERICAN TOBACCO P.L.C. - 10,000,000 ORDINARY SHARES OF 25P EACH
(REF: 0287580) (GB0002875804)

 B)           BRITISH AMERICAN TOBACCO P.L.C. Sharesave Scheme - 1,500,000 Ordinary shares of 25p each (Ref: 0287580) (GB0002875804)

3. Period of return: 

From 1 July 2024 to 31 December 2024                                                            

4. Balances under scheme from previous return:

A)           31,189           

B)           260,850

5. The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return:

N/A

6. Number of securities issued/allotted under scheme during period:

A)        0

B)       95,897

7. Balance under scheme not yet issued/allotted at end of period:

A)        31,189

B)        164,953

8. Number and class of securities originally listed and the date of admission:

A)        10,000,000 listed on 06.12.99 (REF: 0287580) (GB0002875804)

B)        1,500,000 listed on 01.05.15 (REF: 0287580) (GB0002875804)

9. Total number of securities in issue at the end of the period:

2,342,825,304 Ordinary Shares of 25p each which figure includes 133,266,206 shares held in Treasury.

 

Contact for queries:

 

Name: C. Worlock

Address: Globe House, 4 Temple Place, London WC2R 2PG

Telephone: [phone]

Date: 2 January 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

BLRUPUCAGUPAGWP